Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease.
2-Year U.S. Treasury Note Continuous Contract $103.441 0.082 0.08% 5-Year U.S. Treasury Note Continuous Contract $108.398 0.164 0.15% 10-Year U.S. Treasury Note Continuous Contract $112.109 0.250 ...